TABLE 2.

Correlation between levels of protein arginine methyltransferase 5 in the cytoplasm (cPRMT5) and nucleus (nPRMT5) with other clinicopathological characteristics in 102 lung adenocarcinomas

Variable	Number	cPRMT5			nPRMT5
		Low expression	High expression	P‐value	Low expression	High expression	P‐value
Age (y)
≤60	52	22	30		27	25
>60	50	28	22	.167	27	23	.843
Gender
Female	46	27	19		27	19
Male	56	23	33	.076	27	29	.291
Smoking history
Yes	47	27	20		29	18
No	55	23	32	.116	25	30	.101
Tumor location
Left	31	18	13		16	15
Right	71	32	39	.227	38	33	.859
Pathological grade
I‐II	59	34	25		26	33
III	43	16	27	.042*	28	15	.035*
T stage
T1	50	24	26		25	25
T2‐4	52	26	26	.840	29	23	.560
N stage
N0	59	37	22		35	24
N1‐3	43	13	30	.001**	19	24	.130
M stage
M0	99	50	49		52	47
M1	3	0	3	.243	2	1	1.000
TNM stage
I‐II	71	45	26		38	33
III‐IV	31	5	26	<.001**	16	15	.859
Mortality
Survived	46	38	8		28	18
Died	56	12	44	<.001**	26	30	.146

^*P <. 05; **P <.005.